US EditionKymanox® Announces Low Volume Manufacturing Capabilities Supporting Human Clinical Studies
Summary by kalkinemedia.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Kymanox® Announces Low Volume Manufacturing Capabilities Supporting Human Clinical Studies
KING OF PRUSSIA, PA, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Kymanox®, a leading provider of device design and product development, quality, regulatory and technical solutions exclusively serving the Life Science industry, is pleased to announce the successful completion of a significant manufacturing project, with clinical devices manufactured at its King of Prussia facility that are now being utilized in human clinical studies. The co…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
